Prevalence of Drug Resistance-Associated Gene Mutations in Plasmodium vivax in Central China.
- Author:
Feng LU
1
;
Bo WANG
;
Jun CAO
;
Jetsumon SATTABONGKOT
;
Huayun ZHOU
;
Guoding ZHU
;
Kwonkee KIM
;
Qi GAO
;
Eun Taek HAN
Author Information
1. Department of Medical Environmental Biology and Tropical Medicine, Kangwon National University School of Medicine, Chuncheon 200-701, Korea. ethan@kangwon.ac.kr
- Publication Type:Brief Communication ; Research Support, Non-U.S. Gov't
- Keywords:
Plasmodium vivax;
drug-resistance;
mutation;
central China
- MeSH:
Antimalarials/*pharmacology;
China;
Chloroquine/pharmacology;
DNA, Protozoan/chemistry/genetics;
Drug Resistance/*genetics;
Folic Acid Antagonists/pharmacology;
Genotype;
Humans;
Malaria, Vivax/epidemiology/*parasitology;
Plasmodium vivax/drug effects/*genetics/isolation & purification;
Point Mutation;
Polymorphism, Single Nucleotide/*genetics;
Prevalence;
Protozoan Proteins/genetics;
Sequence Analysis, DNA;
Tandem Repeat Sequences/*genetics
- From:The Korean Journal of Parasitology
2012;50(4):379-384
- CountryRepublic of Korea
- Language:English
-
Abstract:
Resistance of Plasmodium spp. to anti-malarial drugs is the primary obstacle in the fight against malaria, and molecular markers for the drug resistance have been applied as an adjunct in the surveillance of the resistance. In this study, we investigated the prevalence of mutations in pvmdr1, pvcrt-o, pvdhfr, and pvdhps genes in temperate-zone P. vivax parasites from central China. A total of 26 isolates were selected, including 8 which were previously shown to have a lower susceptibility to chloroquine in vitro. For pvmdr1, pvcrt-o, and pvdhps genes, no resistance-conferring mutations were discovered. However, a highly prevalent (69.2%), single-point mutation (S117N) was found in pvdhfr gene. In addition, tandem repeat polymorphisms existed in pvdhfr and pvdhps genes, which warranted further studies in relation to the parasite resistance to antifolate drugs. The study further suggests that P. vivax populations in central China may still be relatively susceptible to chloroquine and sulfadoxine-pyrimethamine.
